Literature DB >> 2171418

A clinical triad to diagnose paraneoplastic retinopathy.

D M Jacobson1, C E Thirkill, S J Tipping.   

Abstract

Two elderly men developed photosensitivity and light-induced glare, transient visual symptoms, and progressive visual loss several months before small cell carcinoma of the lung was discovered. Both patients had impaired visual acuity and color vision, ring scotomas, and attenuated retinal arteriole caliber. Electroretinography demonstrated abnormal cone and rod-mediated responses. Antiretinal antibodies were identified in their serum. Their visual sensory function improved following therapy with immunosuppressive agents. The triad of photosensitivity, ring scotomatous visual field loss, and attenuated retinal arteriole caliber should alert one to a paraneoplastic disorder affecting the retina.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171418     DOI: 10.1002/ana.410280208

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.

Authors:  R Peek; B G Dijkstra; B Meek; R W A M Kuijpers
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

3.  Pigmentary retinopathy, macular oedema, and abnormal ERG with mitotane treatment.

Authors:  W T Ng; M G Toohey; L Mulhall; D A Mackey
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  Acute retinal toxicity from the novel anti-tumor agent, Irofulven.

Authors:  Robert F Melendez; Joseph M Harrison; Eric K Rowinsky; Lisa A Hammond; Thomas D Fitzsimmons
Journal:  Doc Ophthalmol       Date:  2004-05       Impact factor: 2.379

Review 5.  The need for standardization of antiretinal antibody detection and measurement.

Authors:  Farzin Forooghian; Ian M Macdonald; John R Heckenlively; Elise Héon; Lynn K Gordon; John J Hooks; Barbara Detrick; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

Review 6.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

8.  Thyroid malignancy presenting with visual loss: an unusual case of paraneoplastic retinopathy.

Authors:  Emily Hughes; Sarah Moran; Ian Flitcroft; Patricia Logan
Journal:  BMJ Case Rep       Date:  2016-10-19

9.  Severe course of cutaneous melanoma associated paraneoplastic retinopathy.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

10.  Cancer-associated retinopathy in patients with breast carcinoma.

Authors:  Marta Misiuk-Hojło; Maria Ejma; Wojciech A Gorczyca; Stanisław Szymaniec; Danuta Witkowska; Wojciech Fortuna; Ryszard Miedzybrodzki; Jadwiga Rogozińska-Szczepka; Wiesława Bartnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.